by In2Pharma | Mar 20, 2023 | News
Belgium The FAMHP would like to remind the pharmaceutical industry regarding the following topics: Pictograms related to the environment and recycling (e.g. green dot pictogram) do not comply with art.56§1 of the Royal Decree on medicines. The current guideline...
by In2Pharma | Jan 26, 2022 | News
The Netherlands The Medicines Evaluation Board (MEB) has revised two policy documents for pharmaceutical companies on the requirements for product information: MEB 5: Package leaflet of pharmaceutical products Update sections 4, 5.1, 6, 6.2, 7, 7.1, 7.4.1 Update Annex...
by In2Pharma | Jun 11, 2021 | News
The Netherlands The Medicines Evaluation Board (MEB) has amended its policy regarding the labeling of medicines for humans (MEB 6). The MEB recognizes the value that pictograms on the packaging can have to clarify the information. Pictograms on the packaging of...
by In2Pharma | Nov 5, 2019 | News
The Netherlands The Medicines Evaluation Board (MEB) invites interested parties and stakeholders to comment on 2 amended policy documents on the labeling of medicines for humans (MEB 6) and the naming of pharmaceutical products (MEB 13). The most important changes are...
by In2Pharma | Feb 12, 2018 | News
FAMHP The guidelines on labeling of medicines have been adapted. With these adaptations, the guidelines are more in line with the European and other national and international guidelines. Main changes are: Information in braille: the strength and/or pharmaceutical...
